The global vascular access devices market, valued at US$5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
4d
GlobalData on MSNNavi lands FDA clearance for vascular access placement systemThe US Food and Drug Administration (FDA) has granted 510(k) clearance to the Neonav electrocardiogram (ECG) tip location system, a central venous access device (CVAD) placement platform developed by ...
9d
GlobalData on MSNChildren’s National Hospital and Compremium partner to advance paediatric medtechThe first-of-its-kind collaboration will pool the entities’ resources to advance the monitoring of pressure conditions.
The risk for cancer increases after cerebral venous thrombosis, especially in men older than 50 years; a new study calls for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results